Cellia Science Awarded $300K+ NIH SBIR Phase I Grant to Develop Point-of-Care Diagnostic for Spontaneous Bacterial Peritonitis
Cellia Science a biotechnology company advancing rapid, cell-based diagnostic technologies, announced today that it has been awarded a $306,872 Small Business Innovation Research (SBIR) Phase I grant from the National...